Ladenburg Thalmann Financial Services’s CASI Pharmaceuticals CASI Stock Holding History
Bought
Maintained
Sold
Other funds holding CASI
IACGFIA
WSCM
WSC
N
Ladenburg Thalmann Financial Services's CASI Position: Q4 2019 in Review
Ladenburg Thalmann Financial Services reduced its CASI Pharmaceuticals (CASI) stake by 2.4% in Q4 2019, selling an estimated $162 and leaving 200 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #4686.
Ladenburg Thalmann Financial Services first reported a position in CASI in Q2 2013 and has held it in 26 quarters since. The position peaked at $9K in Q3 2018. 53 funds tracked by Wall St. Rank hold CASI as of Q4 2019.
- Ladenburg Thalmann Financial Services held 200 shares of CASI Pharmaceuticals worth $6K as of Q4 2019.
- Ladenburg Thalmann Financial Services sold 5 CASI Pharmaceuticals shares in Q4 2019, an estimated $162.
- CASI Pharmaceuticals made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #4686 holding.
- Ladenburg Thalmann Financial Services first reported a position in CASI Pharmaceuticals in Q2 2013 and has held it in 26 quarters since.
- Ladenburg Thalmann Financial Services's CASI Pharmaceuticals position peaked at $9K in Q3 2018.
- 53 funds tracked by Wall St. Rank held CASI Pharmaceuticals as of Q4 2019.
Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.